DeutschNewstral
Article
The Salt Lake Tribune on 2015-04-28 01:17
FDA: Medtronic must stop drug pump sales
Related news
FDA: Medtronic must stop most sales of Synchromed drug pumpsThe Wichita Eagle
FDA deal sharply limits Medtronic infusion pump manufacturing, salesStar Tribune
FDA rejects Intarcia's drug pumpbizjournals.com- FDA files consent decree against Medtronic for "repeatedly failing to correct violations"bizjournals.com
- Medtronic begins to roll out state-of-the-art insulin pumpStar Tribune
- FDA delays decision on muscular dystrophy drugThe Salt Lake Tribune
- FDA panel OKs drug-oozing addiction implantThe Salt Lake Tribune
- Medtronic issues recall of some models of SynchroMed II drug pumpStar Tribune
- FDA approves Medtronic productbizjournals.com
- KGlobal Infusion Pump Device Market Report 2021-2028 Sales, Revenue, Analysis Fresenius Kabi, Medtronic, Moogksusentinel.com
- Medtronic, citing safety issues, halts sales of HVAD implantable heart pumpbizjournals.com
- Medtronic creates $35 million fund for people harmed by drug pump linked to multiple deathsbizjournals.com
- Medtronic ends sales of heart-failure deviceStar Tribune
FDA reviews ALS drug after pushnwaonline.com- Medtronic receives FDA approval for new type of implantable defibrillatorStar Tribune
- FDA OKs drug that uses herpes virus to fight cancerThe Salt Lake Tribune
- FDA weighs OK of first-in-class cholesterol drugThe Salt Lake Tribune